adenosine has been researched along with Cognition Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Gao, L; Li, L; Song, Y; Wang, Q; Zhao, Y | 1 |
| Butler, JP; Klerman, EB; Phillips, AJK | 1 |
| Bonan, CD; Bortolotto, JW; Cognato, Gde P; Melo, GM; Vianna, MR | 1 |
| Balkin, TJ; Grugle, NL; Killgore, DB; Killgore, WD; Muckle, AE | 1 |
| Abel, T; Fellin, T; Florian, C; Frank, MG; Halassa, MM; Haydon, PG; Lee, SY; Munoz, JR | 1 |
| Boison, D; Chen, JF; Lan, JQ; Lytle, N; Shen, HY; Singer, P; Wei, CJ; Williams-Karnesky, RL; Yee, BK | 1 |
| Arendash, GW; Cracchiolo, JR; Jackson, EK; Rezai-Zadeh, K; Schleif, W; Shippy, D; Tan, J; Zacharia, LC | 1 |
| Akahane, A; Aoki, S; Iwashita, A; Matsuda, R; Matsuoka, N; Mihara, K; Mihara, T; Mitani, Y; Yamamoto, H; Yarimizu, J | 1 |
| Pamplona, FA; Prediger, RD; Takahashi, RN | 1 |
| Kapl, D; Rudolphi, KA | 1 |
2 review(s) available for adenosine and Cognition Disorders
| Article | Year |
|---|---|
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.
Topics: Adenosine; Alzheimer Disease; Animals; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Disease Models, Animal; Humans; Learning; Memory; Parkinson Disease; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Receptors, Purinergic P1 | 2008 |
[New pharmacologic aspects in the neurologic profile of propentofylline (Karsivan ad us. vet.)].
Topics: Adenosine; Alzheimer Disease; Animals; Cerebrovascular Circulation; Cognition Disorders; Dementia, Vascular; Dog Diseases; Dogs; Hemodynamics; Humans; Neuroprotective Agents; Phosphodiesterase Inhibitors; Xanthines | 1998 |
8 other study(ies) available for adenosine and Cognition Disorders
| Article | Year |
|---|---|
Comprehensive epigenetic analysis of m6A modification in the hippocampal injury of diabetic rats.
Topics: Adenosine; Animals; Apoptosis; Cell Line; Cognition Disorders; Diabetes Mellitus, Experimental; Epigenesis, Genetic; Hippocampus; Male; Neurons; Rats, Wistar; RNA-Seq | 2020 |
Modeling the adenosine system as a modulator of cognitive performance and sleep patterns during sleep restriction and recovery.
Topics: Adenosine; Attention; Brain; Cognition; Cognition Disorders; Computer Simulation; Humans; Models, Neurological; Psychomotor Performance; Reaction Time; Recovery of Function; Sleep; Sleep Deprivation | 2017 |
Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Avoidance Learning; Cognition Disorders; Dipyridamole; Disease Models, Animal; Motor Activity; Muscarinic Antagonists; Nucleoside Transport Proteins; Purinergic P1 Receptor Antagonists; Scopolamine; Signal Transduction; Social Behavior; Zebrafish | 2015 |
Sex differences in cognitive estimation during sleep deprivation: effects of stimulant countermeasures.
Topics: Adenosine; Adult; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cognition; Cognition Disorders; Dextroamphetamine; Dopamine; Female; Humans; Male; Mental Processes; Modafinil; Neuropsychological Tests; Placebos; Prefrontal Cortex; Sex Characteristics; Sleep Deprivation; Stress, Psychological; Wakefulness; Young Adult | 2008 |
Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Astrocytes; Brain; Cell Communication; Cognition Disorders; Disease Models, Animal; Electroencephalography; Green Fluorescent Proteins; Homeostasis; Injections, Intraventricular; Mice; Mice, Transgenic; Neurons; Receptor, Adenosine A1; Sleep; Sleep Deprivation; SNARE Proteins; Transgenes | 2009 |
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.
Topics: Adenosine; Adenosine Kinase; Amphetamines; Animals; Antipsychotic Agents; Basal Ganglia; Cell Transplantation; Cells, Cultured; Cognition Disorders; Cricetinae; Disease Models, Animal; Endophenotypes; Hippocampus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Psychotic Disorders; Pyrimidines; Receptor, Adenosine A2A; Schizophrenia; Schizophrenic Psychology | 2012 |
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Brain; Caffeine; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Neuropsychological Tests; Peptide Fragments; Presenilin-1; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Treatment Outcome | 2006 |
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; CHO Cells; Cognition Disorders; Cricetinae; Cricetulus; Dopamine; Haloperidol; Humans; Male; Memory Disorders; Mice; Mice, Inbred C57BL; MPTP Poisoning; Phenethylamines; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Scopolamine | 2007 |